solution_going_pro_eyebrow

solution_going_pro_title

solution_going_pro_lede

solution_going_pro_cta_meta

landing_checkout_marketing_notice

solution_going_pro_secondary_cta

4solution_going_pro_block_1_title
+18.4Rsolution_going_pro_section_1_eyebrow
−6.2%solution_going_pro_specimen_row_risk
v4solution_going_pro_specimen_row_strategy

solution_going_pro_specimen_accountsolution_going_pro_specimen_label

LIVE

solution_going_pro_specimen_row_account

+18.4R

solution_going_pro_specimen_row_risk

−6.2%max DD

Activity

142trades

solution_going_pro_specimen_row_accountsolution_going_pro_specimen_account_value
solution_going_pro_specimen_row_strategysolution_going_pro_specimen_strategy_value
solution_going_pro_specimen_row_risksolution_going_pro_specimen_risk_value
solution_going_pro_specimen_row_mentorsolution_going_pro_specimen_mentor_value

solution_going_pro_specimen_caption

solution_going_pro_specimen_oscar

solution_going_pro_section_1_eyebrow

solution_going_pro_section_1_title

solution_going_pro_section_1_body

solution_going_pro_specimen_row_account

solution_going_pro_specimen_account+18.4R
Personal · Live+4.1R
Evaluation · Test−2.0R

solution_going_pro_block_1_title

solution_going_pro_block_1_body

solution_going_pro_specimen_row_strategy

solution_going_pro_block_2_title

solution_going_pro_specimen_strategy_value
solution_going_pro_block_2_title

Live trades

+1.4R38 trades
−0.8R46 trades

edge held

solution_going_pro_block_2_title

solution_going_pro_block_2_body

solution_going_pro_specimen_row_risk

Monthly target+18.4R / +25R
Max drawdown−6.2% / −10%
Daily loss limit−2.0% / −5%

solution_going_pro_block_3_title

solution_going_pro_block_3_body

solution_going_pro_section_2_eyebrow

solution_going_pro_section_2_title

solution_going_pro_section_2_body

solution_going_pro_block_4_title

solution_going_pro_specimen_account

−6.2%

Where did risk increase?Wk 3
Which setup changed?v3 → v4
Which session hurts?PM
Improving for the right reasons?Yes

solution_going_pro_block_4_title

solution_going_pro_block_4_body

solution_going_pro_specimen_row_mentor

solution_going_pro_specimen_row_account
solution_going_pro_block_4_title
Journal context
Evaluation · Test

solution_going_pro_block_5_title

solution_going_pro_block_5_body

solution_going_pro_block_6_title

solution_going_pro_specimen_oscar

solution_going_pro_specimen_caption

solution_going_pro_specimen_row_risk · −6.2% solution_going_pro_specimen_account · v4

solution_going_pro_block_6_title

solution_going_pro_block_6_body

solution_going_pro_section_3_eyebrow

solution_going_pro_section_3_title

solution_going_pro_section_3_body

solution_going_pro_ledger_statement_label

solution_going_pro_ledger_period

solution_going_pro_ledger_col_accountsolution_going_pro_ledger_col_grosssolution_going_pro_ledger_col_net

solution_going_pro_specimen_account+18.4R+16.9R
Personal · Live+4.1R+3.6R
Evaluation · Test−2.0R−2.3R

solution_going_pro_ledger_cost_commission−1.9R
solution_going_pro_ledger_cost_swap−0.6R
solution_going_pro_ledger_cost_fees−0.4R

solution_going_pro_ledger_net_labelsolution_going_pro_ledger_net_sub

+18.2R

solution_going_pro_block_7_title

solution_going_pro_block_7_body

solution_going_pro_capital_label

solution_going_pro_capital_a46%+11.2R
solution_going_pro_capital_b31%+5.1R
solution_going_pro_capital_c23%−0.6R

solution_going_pro_block_8_title

solution_going_pro_block_8_body

solution_going_pro_export_label

solution_going_pro_export_aCSV
solution_going_pro_export_bPDF
solution_going_pro_export_cCSV

solution_going_pro_block_9_title

solution_going_pro_block_9_body

solution_faq_eyebrow

solution_faq_title

solution_going_pro_faq_1_a
solution_going_pro_faq_2_a
solution_going_pro_faq_3_a
solution_going_pro_faq_4_a
solution_going_pro_faq_5_a

solution_going_pro_next_title

solution_going_pro_closing_eyebrow

solution_going_pro_closing_title

solution_going_pro_closing_body

solution_going_pro_cta_meta

landing_checkout_marketing_notice

solution_going_pro_specimen_labelsolution_going_pro_specimen_row_mentor

solution_going_pro_specimen_row_accountsolution_going_pro_specimen_account
solution_going_pro_specimen_row_strategyv4
solution_going_pro_specimen_row_risk−6.2% / −10%
Notesolution_going_pro_specimen_oscar

solution_going_pro_specimen_account_value